Teladoc Health, Inc. 8-K
Research Summary
AI-generated summary
Teladoc Health, Inc. Director Thomas McKinley to Retire
What Happened Teladoc Health, Inc. filed a Form 8-K (Item 5.02) reporting that director Thomas G. McKinley notified the company on February 8, 2026 that he will retire from the Board effective February 20, 2026. Mr. McKinley has served as a director since 2009. The filing states his retirement is for personal reasons and not due to any disagreement with the company.
Key Details
- Filing: Form 8-K (Item 5.02) dated February 12, 2026.
- Notice date: Mr. McKinley notified the company on February 8, 2026.
- Effective date: Retirement effective February 20, 2026.
- Tenure: Director since 2009.
- Company statement: Retirement is for personal reasons; no disagreement with the company.
- Report signed by Adam C. Vandervoort, Chief Legal Officer and Secretary.
Why It Matters A board member departure is a governance change investors should note. Mr. McKinley’s long tenure (since 2009) means the Board is losing an experienced director, though the company indicates the exit is voluntary and not due to any dispute. The 8-K does not announce a successor or Board replacement timeline; investors may watch for future filings or proxy materials for any nomination or Board composition updates.